NCT02875223 2025-04-20A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's LymphomasCelgenePhase 1 Terminated75 enrolled 35 charts
NCT04748848 2023-03-02A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive TherapyCelgenePhase 1 Terminated1 enrolled